[1]曹 晋,拜 珂,安 欣,等.超重和肥胖合并2型糖尿病微量白蛋白尿患者维生素D营养状况临床分析[J].陕西医学杂志,2021,50(7):850-853.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.021]
　CAO Jin,BAI Ke,AN Xin,et al.Analysis of vitamin D nutrition status in overweight and obese patients with T2DM and microalbuminuria[J].,2021,50(7):850-853.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.021]
点击复制

超重和肥胖合并2型糖尿病微量白蛋白尿患者维生素D营养状况临床分析
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
50
期数:
2021年7期
页码:
850-853
栏目:
临床研究
出版日期:
2021-07-05

文章信息/Info

Title:
Analysis of vitamin D nutrition status in overweight and obese patients with T2DM and microalbuminuria
作者:
曹 晋1; 拜 珂2; 安 欣3; 邵 英1
(1.空军第九八六医院内分泌科,陕西 西安 710054; 2.延安大学医学院,陕西 延安 716000; 3.西安工会医院,陕西 西安 710100)
Author(s):
CAO Jin; BAI Ke; AN Xin; SHAO Ying
(Department of Endocrinology,the 986th Hospital of Air Force,Xi'an 710054,China)
关键词:
超重;  肥胖症;  2型糖尿病;  微量白蛋白尿;  维生素D;  25-羟基维生素D
Keywords:
Overweight;  Obesity;  T2DM;  Microalbuminuria;  Vitamin D;  25-hydroxy-vitamin D
分类号:
R 587.1
DOI:
DOI:10.3969/j.issn.1000-7377.2021.07.021
文献标志码:
A
摘要:
目的:探讨超重和肥胖合并2型糖尿病微量白蛋白尿(MAU)患者维生素D营养状况。方法:选取收治的189例超重和肥胖的初诊2型糖尿病患者,按照是否合并MAU分为两组,分别为非MAU组[24 h尿白蛋白排泄率(24 hUAER)<30 mg/24 h,n=129例]和MAU组(24 hUAER≥30 mg/24 h,n=60例)。比较两组的实验室检查指标,采用单因素Pearson相关性分析和多因素Logistic回归方程分析MAU和维生素D营养状况的关系。结果:与非MAU组比较,MAU组收缩压(SBP)、舒张压(DBP)、糖化血红蛋白(HbA1c)、胰岛素抵抗指数(HOMA-IR)、甘油三酯(TG)、血尿酸、同型半胱氨酸(Hcy)水平、维生素D不足或缺乏比例较高,差异有统计学意义(均P<0.05),高密度脂蛋白胆固醇(HDL-C)、血清25-羟基维生素D[25(OH)D]水平较低,差异有统计学意义(均P<0.05)。与维生素D正常组比较,维生素D不足或缺乏组HbA1c、HOMA-IR、24 hUAER水平较高,差异有统计学意义(均P<0.05)。Pearson相关性分析显示24 hUAER与SBP 、DBP 、HbA1c、HOMA-IR、TG、血尿酸、Hcy呈正相关(均P<0.05),与HDL-C、25(OH)D呈负相关(均P<0.05)。多因素Logistic回归方程显示维生素D不足或缺乏是超重和肥胖合并2型糖尿病合并MAU的独立危险因素(P<0.05)。结论:超重和肥胖合并2型糖尿病合并MAU患者中维生素D营养状况不佳,维生素D不足或缺乏检出率偏高,可能是MAU发生的独立危险因素,值得临床关注。
Abstract:
Objective:To investigate the nutritional status of vitamin D in overweight and obese patients with T2DM and microalbuminuria(MAU).Methods:189 cases of overweight and obese patients with T2DM were selected.According to whether combined with MAU,they were divided into non-MAU group [24-hour urinary albumin excretion rate(24 hUAER)<30 mg/24 h,129 cases] and MAU group(24 hUAER ≥30 mg/24 h,60 cases).The laboratory test indicators of the two groups were compared,and the single factor Pearson correlation analysis and the multivariate Logistic regression equation were used to analyze the relationship between MAU and vitamin D nutritional status.Result:Compared with non-MAU group,the levels of SBP,DBP,HbA1c,HOMA-IR,TG,UA,Hcy,and the proportion of vitamin D insufficient or lack in MAU group were higher,and the levels of HDL-C and 25(OH)D were lower(all P<0.05).Compared with the normal vitamin D group,the levels of HbA1c,HOMA-IR and 24 hUAER in the vitamin D deficiency or deficiency group were higher(all P<0.05).Pearson correlation analysis showed that 24 hUAER was positively correlated with SBP,DBP,HbA1c,HOMA-IR,TG,blood uric acid,and Hcy,and negatively correlated with HDL-C and 25(OH)D(all P<0.05).Multivariate Logistic regression analysis showed that insufficient or lack of vitamin D was an independent risk factor for overweight and obese patients with T2DM and MAU(P<0.05).Conclusion:The nutritional status of vitamin D in overweight and obese patients with T2DM and MAU is not good,and the detection rate of vitamin D insufficient or lack is high,which may be an independent risk factor of MAU,which deserves clinical attention.

参考文献/References:

[1] 中华医学会内分泌学分会.中国2 型糖尿病合并肥胖综合管理专家共识[J].中华内分泌代谢杂志,2016,32(8):623-627.
[2] 中国肥胖问题工作组.中国成人超重与肥胖症预防与控制指南(节录)[J].营养学报,2004,26(1):1-4.
[3] Gawandi S,Gangawane S,Chakrabarti A,et al.A study of microalbuminuria and advanced glycation end products levels in diabetic and hypertensive subjects[J].Indian Journal of Clinical Biochemistry,2018,33(s1):1-5.
[4] Jiang X,Peng M,Chen S,et al.Vitamin D deficiency is associated with dyslipidemia:A cross-sectional study in 3788 subjects[J].Curr Med Res Opin,2019,35(6):1059-1063.
[5] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-67.
[6] 廖祥鹏,张增利,张红红,等.维生素D与成年人骨骼健康应用指南(2014年 简化版)[J].中国骨质疏松杂志,2014,20(6):1011-1030.
[7] Lv X,Ran X,Chen X,et al.Early-onset type 2 diabetes:A high-risk factor for proliferative diabetic retinopathy(PDR)in patients with microalbuminuria[J].Medicine,2020,99(19):e20189.
[8] 中华医学会糖尿病学分会微血管并发症学组.糖尿病肾病防治专家共识(2014年版)[J].中华糖尿病杂志,2014,6(11):792-801.
[9] Mu Y,Kou T,Wei B,et al.Soy products ameliorate obesity-related anthropometric indicators in overweight or obese asian and non-menopausal women:A meta-analysis of randomized controlled trials[J].Nutrients,2019,11(11):145-152.
[10] Seki N,Matsumoto T,Fukazawa M.Relationship between the brain natriuretic peptide(BNP)level and prognosis of diabetic nephropathy with microalbuminuria:A 7-year follow-up study[J].Hormone and Metabolic Research,2018,27(11):389-396.
[11] Currie GE,Scholten BV,Mary S,et al.Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria[J].Cardiovascular Diabetology,2018,17(1):50-57.
[12] 尹一帆.钠-葡萄糖协同转运蛋白2抑制剂对糖尿病肾病治疗作用的研究进展[J].医学研究生学报,2020,33(1):97-102.
[13] 龚 彤,韩 雪,胡 欣,等.不同体重的住院2型糖尿病患者血清维生素D水平与血脂之间的关系[J].中华内分泌代谢杂志,2020,36(12):1032-1038.
[14] 董志萍,宋振强,丛 毓,等.成人肥胖患者血清25羟维生素D3水平及其与糖脂代谢指标相关性研究[J].军事医学,2020,44(10):762-766.
[15] Walsh JS,Evans AL,Bowles S,et al.Free 25-hydroxyvitamin D is low in obesity,but there are no adverse associations with bone health[J].Am J Clin Nutr,2016,103(6):1465-1471.
[16] Kim H,Lee H,Yim HW,et al.Association of serum 25-hydroxyvitamin D and diabetes-related factors in korean adults without diabetes:The fifth korea national health and nutrition examination survey 2010-2012[J].Primary Care Diabetes,2018,42(6):1231-1239.
[17] Maddaloni E,Cavallari I,Napoli N,et al.Vitamin D and diabetes mellitus [J].Frontiers of Hormone Research,2018,50(9):161-176.
[18] Prabhu RA,Saraf K.Vitamin D in diabetic nephropathy[J].Journal of Postgraduate Medicine,2018,64(1):5-6.
[19] Trohatou O,Tsilibary EF,Charonis A,et al.Vitamin D3 ameliorates podocyte injury through the nephrin signaling pathway[J].J Cell Mol Med,2017,21(10):2599-2609.
[20] Maclennan WJ,Hamilton JC.Vitamin D supplements and 25-hydroxy vitamin D concentrations in the elderly [J].British Medical Journal,2019,34(10):859-865.

相似文献/References:

[1]杨 旭,张致英,康龙丽,等.环状RNA与代谢性疾病研究进展[J].陕西医学杂志,2021,50(1):126.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.033]
　YANG Xu,ZHANG Zhiying,KANG Longli,et al.Advances in circular RNA and metabolic diseases[J].,2021,50(7):126.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.033]

备注/Memo

备注/Memo:
基金项目:陕西省科技计划项目(2019SF149)
更新日期/Last Update: 2021-07-05